EC proposes “HERA Incubator” initiative to pre-empt the threat of COVID-19 variants

The European Commission (EC) has proposed an action plan called the “HERA Incubator” to shape the European Union’s (EU’s) strategy for combating the threat of future COVID-19 variants. The initiative is modelled on the annual influenza vaccine programme. Read more “EC proposes “HERA Incubator” initiative to pre-empt the threat of COVID-19 variants”

MHRA provides guidance on managing COVID-19 vaccine deployment for ongoing non-COVID-19 clinical trials

The Medicines and Healthcare products Regulatory Agency (MHRA) have updated their guidance document on managing clinical trials during COVID-19 with a new section pertaining to the management of non-COVID-19 trials in the context of the current COVID-19 vaccination programme. Read more “MHRA provides guidance on managing COVID-19 vaccine deployment for ongoing non-COVID-19 clinical trials”